Overview

Refractory Status Epilepticus Treatment Study

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Identify the most effective dose of valproic acid when used in combination with phenytoin for treatment of patients with refractory status epilepticus, which allow a better clinical course and prognosis of the disease.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Universitari de Bellvitge
Collaborators:
Germans Trias i Pujol Hospital
Hospital Clinic of Barcelona
Hospital Vall d'Hebron
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Treatments:
Phenytoin
Valproic Acid